PhD clusters and funded PhDs
Addressing Health Inequalities in Advanced Illness
This PhD cluster comprises cross-Faculty interlinked PhD scholarships, to address health inequalities in advanced illness at regional, national, and international levels.
In the United Kingdom, demographic changes mean the proportion of older people is growing fast, with a rapid increase in the number of people living with advanced illnesses, including long-term conditions, complex multi-morbidities, and frailty. Integrated approaches to care are essential, if effective and efficient solutions to these challenges are to be found.
Funded PhD in this cluster:
The development of cancer pain education resources for patients from ethnically diverse communities in Humber and North Yorkshire and the health professionals caring for them
Supervisors: Professor Jonathan Koffman and Dr Gertrude Nyaaba
Developing and evaluating a serious game to enable voluntary, community & social enterprises to engage and work with communities about advanced illness
Supervisors: Dr Mark Pearson ad Dr Steven Forrest
Integrated care systems: can they reduce health inequalities for patients with advanced disease?
Supervisors: Dr Joanne Cairns and Professor Una Macleod
Roles and experiences of informal carers providing care to people with advanced illness in sub-Saharan Africa
Supervisors: Dr Joseph Clark and Professor Fliss Murtagh
Diabetes and its comorbidities: a multidisciplinary approach
Diabetes is a multifaceted disease that reduces life quality and expectancy through a plethora of health complications. As the number of people living with diabetes is increasing, the societal impact of this disease is predicted to rise significantly in the next decades.
The complexity of diabetes requires a multidisciplinary research approach to understand its mechanisms and deliver novel therapeutic tools. This PhD cluster will bring together a multidisciplinary team from five different Schools within the University of Hull to investigate the fundamental aspects of diabetes.
Funded PhDs in this cluster:
Dementia and diabetes: the challenges posed by comorbidity
Supervisors: Dr Emma Wolverson (main supervisor), Dr Andrea Hilton, Professor Tim Palmer, Miss Liz Wells, Dr Giordano Pula
Development and characterisation of novel antioxidant H2S-releasing compounds to prevent diabetic kidney disease
Supervisors: Dr Sam Xu (main supervisor), Professor Thozhukat Sathyapalan, Dr Andrew Boa, Dr Giordano Pula, Professor Sunil Bhandari
Diabetes and thrombosis: mechanistic links and novel interventional opportunities
Supervisors: Dr Giordano Pula (main supervisor), Professor Tim Palmer, Professor Thozhukat Sathyapalan, Dr Vicky Green, Dr Ahmed Aburima
The underlying causes of the diabetic foot: revascularisation deficit and novel strategies to boost healing
Supervisors: Dr Holly Wilkinson (main supervisor), Professor Mat Hardman, Dr Giordano Pula, Dr Rebecca Vince
Theragnostics for the Management and Treatment of Disease
Theragnostics combines therapy and diagnosis into a single, unified strategy for the management and treatment of disease. The Hull Molecular Imaging Centres (HuMIC) is currently implementing the latest clinically approved theragnostic technology into routine practice at Castle Hill Hospital and planning clinical trials for the benefit of patients in Hull, East Yorkshire and the surrounding area.
To progress our own research in this area and capitalise on our world-class expertise and scientific/clinical infrastructure, we recently formed the Hull University Theragnostics (HUT) cluster, to assemble four PhD studentships pioneering new theragnostic technology and its application to disease.
Funded PhDs in this cluster:
Development and translation of theragnostic agents
Supervisors: Professor Steve Archibald (primary supervisor) Dr Vicky Brown and Professor Ged Avery (secondary supervisors)
Identifying the next generation of theragnostic targets in cancer
Supervisors: Dr Isabel Pires (primary supervisor), Dr Yongqiang Cheng and Dr Louis Allott (secondary supervisors)
Molecular Imaging and Theragnostics for Wound Healing
Supervisors: Dr Holly Wilkinson (primary supervisor), Professor Mat Hardman and Professor Steve Archibald (co-supervisors)
New strategies for the modular design of theragnostic radiopharmaceuticals
Supervisors: Dr Louis Allott (primary supervisor) Dr Azeem Saleem and Professor Carl Redshaw (secondary supervisors)